QTLs in Region (GRCr8)
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat |
2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) | 14 | 3813074 | 18274691 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat |
71115 | Niddm15 | Non-insulin dependent diabetes mellitus QTL 15 | 4.8 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1217606 | 11030812 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
70204 | Niddm20 | Non-insulin dependent diabetes mellitus QTL 20 | 5.1 | 0.000008 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 1217606 | 16960180 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat |
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat |
2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) | 14 | 3813074 | 18274691 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat |
71115 | Niddm15 | Non-insulin dependent diabetes mellitus QTL 15 | 4.8 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1217606 | 11030812 | Rat |
61450 | Ciaa3 | CIA Autoantibody QTL 3 | 6.5 | | blood autoantibody amount (VT:0003725) | calculated serum anti-type 2 collagen antibody titer (CMO:0001279) | 9 | 7954720 | 22071169 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat |
1354650 | Despr5 | Despair related QTL 5 | 4.01 | 0.0017 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 9 | 1254084 | 46254084 | Rat |
1300124 | Cm4 | Cardiac mass QTL 4 | 3.55 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 9 | 1 | 40594091 | Rat |
70226 | Eae4 | Experimental allergic encephalomyelitis QTL 4 | | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) | 9 | 1 | 25661317 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
631211 | Bw4 | Body weight QTL4 | 5.31 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 9 | 5109826 | 50109826 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat |
10054141 | Gmadr4 | Adrenal mass QTL 4 | 2.45 | 0.0074 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 9 | 1 | 14209783 | Rat |
2303559 | Gluco54 | Glucose level QTL 54 | 2 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 9 | 1254084 | 46254084 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat |
1578675 | Bss17 | Bone structure and strength QTL 17 | 3.8 | | femur morphology trait (VT:0000559) | femoral neck cortical cross-sectional area (CMO:0001702) | 9 | 3368652 | 13533896 | Rat |
9589055 | Scfw5 | Subcutaneous fat weight QTL 5 | 5.55 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 9 | 1 | 37999212 | Rat |
1641911 | Alcrsp13 | Alcohol response QTL 13 | | | response to alcohol trait (VT:0010489) | brain neurotensin receptor 1 density (CMO:0002068) | 9 | 1 | 43718459 | Rat |
61425 | Cia15 | Collagen induced arthritis QTL 15 | 4.6 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 9 | 5109826 | 42921101 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
9589158 | Gluco65 | Glucose level QTL 65 | 6.82 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 9 | 1 | 37999212 | Rat |
10054125 | Srcrt7 | Stress Responsive Cort QTL 7 | 3.33 | 0.0011 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 9 | 1 | 87073594 | Rat |
11353947 | Bp392 | Blood pressure QTL 392 | | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 9 | 7283252 | 52283252 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat |
7411592 | Foco8 | Food consumption QTL 8 | 7.4 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 9 | 1 | 37999212 | Rat |
1331757 | Cdexp1 | CD45RC expression in CD8 T cells QTL 1 | 4.3 | | CD8-positive T cell quantity (VT:0008077) | blood CD45RC(high) CD8 T cell count to CD45RC(low) CD8 T cell count ratio (CMO:0001990) | 9 | 1024537 | 67509080 | Rat |
1298088 | Edpm11 | Estrogen-dependent pituitary mass QTL 11 | 2.5 | | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 9 | 1 | 43718459 | Rat |
70204 | Niddm20 | Non-insulin dependent diabetes mellitus QTL 20 | 5.1 | 0.000008 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 1217606 | 16960180 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat |